NO20073575L - Farmasoytiske sammensetninger for behandling av cellulitt - Google Patents

Farmasoytiske sammensetninger for behandling av cellulitt

Info

Publication number
NO20073575L
NO20073575L NO20073575A NO20073575A NO20073575L NO 20073575 L NO20073575 L NO 20073575L NO 20073575 A NO20073575 A NO 20073575A NO 20073575 A NO20073575 A NO 20073575A NO 20073575 L NO20073575 L NO 20073575L
Authority
NO
Norway
Prior art keywords
cellulite
treatment
pharmaceutical compositions
mesotherapy
active ingredient
Prior art date
Application number
NO20073575A
Other languages
English (en)
Norwegian (no)
Inventor
Alessandro Giolitti
Massimiliana Landini
Sandro Giuliani
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20042371 external-priority patent/ITMI20042371A1/it
Priority claimed from ITMI20051739 external-priority patent/ITMI20051739A1/it
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of NO20073575L publication Critical patent/NO20073575L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20073575A 2004-12-14 2007-07-10 Farmasoytiske sammensetninger for behandling av cellulitt NO20073575L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20042371 ITMI20042371A1 (it) 2004-12-14 2004-12-14 Composizioni farmaceutiche topiche per il trattamento della cellulite
ITMI20051739 ITMI20051739A1 (it) 2005-09-20 2005-09-20 Composizioni farmaceutiche topiche per il trattamento della cellulite
PCT/EP2005/013041 WO2006063714A1 (fr) 2004-12-14 2005-12-06 Préparations pharmaceutiques pour le traitement de la cellulite

Publications (1)

Publication Number Publication Date
NO20073575L true NO20073575L (no) 2007-09-13

Family

ID=35708888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073575A NO20073575L (no) 2004-12-14 2007-07-10 Farmasoytiske sammensetninger for behandling av cellulitt

Country Status (18)

Country Link
US (1) US20100016324A1 (fr)
EP (1) EP1824463A1 (fr)
JP (1) JP2008523127A (fr)
KR (1) KR20070086101A (fr)
AR (1) AR052048A1 (fr)
AU (1) AU2005315919B2 (fr)
BR (1) BRPI0518554A2 (fr)
CA (1) CA2590288A1 (fr)
HK (1) HK1111599A1 (fr)
IL (1) IL183893A0 (fr)
MA (1) MA29145B1 (fr)
MX (1) MX2007007015A (fr)
NO (1) NO20073575L (fr)
NZ (1) NZ555836A (fr)
PE (1) PE20060746A1 (fr)
RU (1) RU2401098C2 (fr)
TN (1) TNSN07203A1 (fr)
WO (1) WO2006063714A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100963268B1 (ko) 2006-11-22 2010-06-11 에스케이케미칼주식회사 실로스타졸과 은행잎 추출물을 함유한 약제 조성물
ITMI20070604A1 (it) * 2007-03-26 2008-09-27 Menarini Farma Ind Preparazioni cosmetiche per la riduzione degli inestetismi della cellulite
BRPI1007812B1 (pt) * 2009-03-02 2017-09-26 Doris Maria Hexsel Lipoatrofia cosmetic medicinal
MY170724A (en) 2012-01-27 2019-08-27 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
CN104161756B (zh) * 2014-06-13 2017-02-01 河北智同医药控股集团有限公司 一种盐酸奥普力农注射液组合物
EA031658B1 (ru) * 2017-06-30 2019-02-28 Акционерное Общество "Верофарм" Антицеллюлитный косметический комплекс
RU2694898C1 (ru) * 2018-08-29 2019-07-18 Талагаева Елена Владимировна Крем для лица и тела

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147497A (en) 1977-01-04 1979-04-03 Gte Sylvania Incorporated Hand-operable signal device using percussively-ignitable flashlamps
IT1270602B (it) 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
JP3452986B2 (ja) * 1994-09-13 2003-10-06 花王株式会社 脂肪分解促進剤
JP4182183B2 (ja) 1999-08-24 2008-11-19 ディーエスエム アイピー アセッツ ビー．ブイ． 痩身用皮膚化粧料
FR2802811B1 (fr) * 1999-12-24 2002-02-15 Silab Sa Procede d'extraction d'un principe actif a partir de petales de bigarade, notamment pour le traitement de la cellulite, principe actif obtenu, compositions cosmetiques et traitements adaptes
US20010041708A1 (en) * 2000-02-15 2001-11-15 Zen-Bio, Inc. Compositions for preventing cellulite in mammalian skin
DE10009423A1 (de) 2000-02-28 2001-09-06 Henkel Kgaa Kosmetische und pharmazeutische Zubereitungen
DE10009424A1 (de) 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
ITMI20011182A1 (it) * 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat

Also Published As

Publication number Publication date
EP1824463A1 (fr) 2007-08-29
MA29145B1 (fr) 2008-01-02
KR20070086101A (ko) 2007-08-27
AU2005315919B2 (en) 2011-06-09
NZ555836A (en) 2009-09-25
BRPI0518554A2 (pt) 2008-11-25
HK1111599A1 (en) 2008-08-15
IL183893A0 (en) 2007-10-31
AR052048A1 (es) 2007-02-28
US20100016324A1 (en) 2010-01-21
PE20060746A1 (es) 2006-09-06
RU2401098C2 (ru) 2010-10-10
MX2007007015A (es) 2007-07-04
CA2590288A1 (fr) 2006-06-22
TNSN07203A1 (en) 2008-11-21
RU2007120465A (ru) 2009-01-27
JP2008523127A (ja) 2008-07-03
AU2005315919A1 (en) 2006-06-22
WO2006063714A1 (fr) 2006-06-22

Similar Documents

Publication Publication Date Title
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
WO2005039485A3 (fr) Inhibiteurs de gsk-3 et utilisations
BRPI0406911A (pt) Produto farmacêutico e/ou cosmético
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO340679B1 (no) Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
TR200102020T2 (tr) Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler.
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
WO2008028965A3 (fr) Inhibiteurs de la protéine phosphatase 1, de gadd34 et du complexe protéine phosphatase 1/gadd34, leur préparation et leurs applications
NO20082269L (no) Nye piperaziner som antimalariamidler
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
BRPI0313148B8 (pt) formulações sólidas matriciais de lamotrigina contendo revestimento externo e perfuração em tal revestimento
CA2494473A1 (fr) Compositions de proteines stabilisees pour administration topique et methodes pour les produire
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
PT1414467E (pt) Tratamento topico da mastalgia
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application